Magnum Experiment 31

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 31, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Apr 11, 2020, Magnum Experiment 31's average daily return is +0.16%, while the average monthly return is +5.06%. At this rate, an investment would double in approximately 1.2 years.

Historically, 62% of months were positive and 38% were negative. The best month was Feb 2021 with a return of +78.1%, while the worst month was May 2021 at -14.6%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, Magnum Experiment 31 closed higher 55% of trading days. The best single day was Feb 19, 2021 with a return of +24.1%, while the worst single day was May 19, 2021 at -14.9%.

Magnum Experiment 31 has an annualized alpha of 26.74%, beta of 1.04, and R² of 0.33 versus S&P 500 Index. Calculated based on daily prices since April 11, 2020.

• This portfolio captured 195.40% of S&P 500 Index gains but only 95.95% of its losses — a favorable profile for investors.
• R² of 0.33 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Magnum Experiment 31 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Magnum Experiment 31 ranks 11 for risk / return — in the bottom 11% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Magnum Experiment 31 Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

• 1-Year: 1.28
• 5-Year: 1.01
• All Time: 1.97

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Magnum Experiment 31 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Magnum Experiment 31 provided a 1.19% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Magnum Experiment 31. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 31 was 34.04%, occurring on Jun 16, 2022. Recovery took 511 trading sessions.

The current Magnum Experiment 31 drawdown is 12.11%.

The chart below shows the rolling one-month volatility.